NASDAQ:AEMD Aethlon Medical (AEMD) Stock Price, News & Analysis → Young billionaire opens the door for millions of Americans (From Porter & Company) (Ad) Free AEMD Stock Alerts $0.50 -0.08 (-13.81%) (As of 06/28/2024 08:55 PM ET) Add Compare Share Share Today's Range$0.48▼$0.5550-Day Range$0.40▼$1.5352-Week Range$0.37▼$5.00Volume1.71 million shsAverage Volume2.24 million shsMarket Capitalization$1.31 millionP/E RatioN/ADividend YieldN/APrice Target$7.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends Get Aethlon Medical alerts: Email Address Aethlon Medical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside1,303.6% Upside$7.00 Price TargetShort InterestBearish29.15% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.41Based on 9 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.46 out of 5 stars 3.5 Analyst's Opinion Consensus RatingAethlon Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageAethlon Medical has only been the subject of 1 research reports in the past 90 days.Read more about Aethlon Medical's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted29.15% of the float of Aethlon Medical has been sold short.Short Interest Ratio / Days to CoverAethlon Medical has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Aethlon Medical has recently increased by 453.96%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldAethlon Medical does not currently pay a dividend.Dividend GrowthAethlon Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AEMD. Previous Next 3.0 News and Social Media Coverage News SentimentAethlon Medical has a news sentiment score of 0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.86 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Aethlon Medical this week, compared to 1 article on an average week.Search Interest18 people have searched for AEMD on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.MarketBeat Follows6 people have added Aethlon Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Aethlon Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.00% of the stock of Aethlon Medical is held by insiders.Percentage Held by InstitutionsOnly 1.99% of the stock of Aethlon Medical is held by institutions.Read more about Aethlon Medical's insider trading history. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Aethlon Medical is -0.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aethlon Medical is -0.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAethlon Medical has a P/B Ratio of 0.08. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Aethlon Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyYoung billionaire opens the door for millions of AmericansYou can now profit from a catalog of 11 inventions that will likely make their way into millions of U.S. households in the months and years to come. And you can do this whether you’re rich or poor… There are no special income requirements.Anyone can do this. About Aethlon Medical Stock (NASDAQ:AEMD)Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.Read More AEMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AEMD Stock News HeadlinesJune 27, 2024 | investorplace.comAEMD Stock Earnings: Aethlon Medical Beats EPS for Q4 2024June 27, 2024 | prnewswire.comAethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate UpdateJuly 1, 2024 | InvestorPlace (Ad)Jeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market…June 24, 2024 | americanbankingnews.comAethlon Medical (AEMD) Set to Announce Quarterly Earnings on ThursdayJune 24, 2024 | americanbankingnews.comHC Wainwright Cuts Aethlon Medical (NASDAQ:AEMD) Price Target to $7.00June 24, 2024 | americanbankingnews.comAethlon Medical (NASDAQ:AEMD) Receives New Coverage from Analysts at StockNews.comJune 21, 2024 | prnewswire.comAethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024June 18, 2024 | prnewswire.comAethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer TrialJuly 1, 2024 | Porter & Company (Ad)Trump’s arrest is phase oneIn this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election… June 6, 2024 | investorplace.comWhy Is Aethlon Medical (AEMD) Stock Up 82% Today?June 3, 2024 | prnewswire.comAethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment StudiesMay 15, 2024 | prnewswire.comAethlon Medical Announces Pricing of $4.7 Million Public OfferingMay 10, 2024 | markets.businessinsider.comAethlon Medical Stock Surges In Pre-market On Positive Hemopurifier Trial ResultsMay 10, 2024 | marketwatch.comAethlon Medical Shares Double After Positive Results from Early Trial of HemopurifierMay 10, 2024 | prnewswire.comAethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient PlasmaMarch 25, 2024 | money.usnews.comAethlon Medical IncMarch 4, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (CNTB), Aethlon Medical (AEMD) and Aclaris Therapeutics (ACRS)March 2, 2024 | investing.comAethlon Medical Inc (AEMD)February 21, 2024 | finanznachrichten.deAethlon Medical, Inc.: Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture DevicesFebruary 21, 2024 | markets.businessinsider.comAethlon Inks Materials Transfer Deal For Santersus' NucleoCapture And HemoNucleoCapture DevicesFebruary 21, 2024 | finance.yahoo.comAethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture DevicesFebruary 21, 2024 | prnewswire.comAethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture DevicesFebruary 18, 2024 | finanznachrichten.deAethlon Medical, Inc.: Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate UpdateFebruary 15, 2024 | finance.yahoo.comAEMD: Focus on Oncology Studies; In Vitro Binding Study Expected to Advance Clinical Trial ActivitiesFebruary 15, 2024 | finance.yahoo.comAethlon Medical, Inc. (NASDAQ:AEMD) Q3 2024 Earnings Call TranscriptFebruary 14, 2024 | finance.yahoo.comAethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate UpdateFebruary 14, 2024 | prnewswire.comAethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate UpdateSee More Headlines Receive AEMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aethlon Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/10/2023Today6/30/2024Next Earnings (Estimated)8/08/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:AEMD CUSIPN/A CIK773910 Webwww.aethlonmedical.com Phone(858) 459-7800FaxN/AEmployees15Year FoundedN/APrice Target and Rating Average Stock Price Target$7.00 High Stock Price Target$7.00 Low Stock Price Target$7.00 Potential Upside/Downside+1,303.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($4.80) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-12,030,000.00 Net MarginsN/A Pretax Margin-2,133.97% Return on Equity-117.98% Return on Assets-93.74% Debt Debt-to-Equity RatioN/A Current Ratio3.93 Quick Ratio3.93 Sales & Book Value Annual Sales$570,000.00 Price / Sales2.29 Cash FlowN/A Price / Cash FlowN/A Book Value$6.56 per share Price / Book0.08Miscellaneous Outstanding Shares2,620,000Free Float2,515,000Market Cap$1.31 million OptionableNo Data Beta1.60 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Guy F. Cipriani BS (Eng.) (Age 53)MBA, Chief Operating Officer Comp: $347.5kDr. Steven P. LaRosa M.D. (Age 57)Chief Medical Officer Comp: $430kMr. James B. Frakes M.B.A. (Age 67)Interim CEO, CFO, Secretary & Director Comp: $385kDr. Lee D. Arnold Ph.D. (Age 64)Chief Scientific Officer Key CompetitorsVenus ConceptNASDAQ:VEROTitan MedicalNASDAQ:TMDIFXylo TechnologiesNASDAQ:XLYOSharps TechnologyNASDAQ:STSSINVO BioscienceNASDAQ:INVOView All Competitors AEMD Stock Analysis - Frequently Asked Questions Should I buy or sell Aethlon Medical stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aethlon Medical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" AEMD shares. View AEMD analyst ratings or view top-rated stocks. What is Aethlon Medical's stock price target for 2024? 1 brokerages have issued 1-year target prices for Aethlon Medical's shares. Their AEMD share price targets range from $7.00 to $7.00. On average, they expect the company's share price to reach $7.00 in the next year. This suggests a possible upside of 1,303.6% from the stock's current price. View analysts price targets for AEMD or view top-rated stocks among Wall Street analysts. How have AEMD shares performed in 2024? Aethlon Medical's stock was trading at $2.19 at the start of the year. Since then, AEMD stock has decreased by 77.2% and is now trading at $0.4987. View the best growth stocks for 2024 here. Are investors shorting Aethlon Medical? Aethlon Medical saw a increase in short interest in June. As of June 15th, there was short interest totaling 2,510,000 shares, an increase of 454.0% from the May 31st total of 453,100 shares. Based on an average trading volume of 4,190,000 shares, the short-interest ratio is presently 0.6 days. Approximately 29.2% of the company's stock are sold short. View Aethlon Medical's Short Interest. When is Aethlon Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 8th 2024. View our AEMD earnings forecast. How were Aethlon Medical's earnings last quarter? Aethlon Medical, Inc. (NASDAQ:AEMD) released its earnings results on Thursday, June, 27th. The medical equipment provider reported ($0.91) earnings per share for the quarter, beating analysts' consensus estimates of ($1.18) by $0.27. During the same quarter last year, the company earned ($1.10) earnings per share. When did Aethlon Medical's stock split? Aethlon Medical shares reverse split before market open on Thursday, October 5th 2023. The 1-10 reverse split was announced on Wednesday, October 4th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, October 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What other stocks do shareholders of Aethlon Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aethlon Medical investors own include Amarin (AMRN), Nokia Oyj (NOK), Vaxart (VXRT), VBI Vaccines (VBIV), Nabriva Therapeutics (NBRV), CRISPR Therapeutics (CRSP), Novavax (NVAX), Organigram (OGI), AT&T (T) and How do I buy shares of Aethlon Medical? Shares of AEMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:AEMD) was last updated on 7/1/2024 by MarketBeat.com Staff From Our Partners270x more lucrative than NVIDIA???If you've missed out on NVIDIA's recent 1,600% run... Don't worry. Because there's one AI stock that cou...Behind the Markets | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredYoung billionaire opens the door for millions of AmericansYou can now profit from a catalog of 11 inventions that will likely make their way into millions of U.S. house...Porter & Company | SponsoredThe End of Privacy for Americans… Get Out of Cash Now!Unlock the Secret to Outsmarting Inflation with "The Trump Loophole" That investment? Gold.Golden Crest | SponsoredBiden Replacement: The Final ChapterLast night’s debate proved me right: Joe Biden will be replaced. And how the face of America will be change...The Freeport Society | SponsoredWill Biden Be Replaced?There are growing rumors of a possible Joe Biden replacement following his first debate against Donald Trump. ...Stansberry Research | SponsoredBuy this small stock before coming AI Tidal WaveThe internet generated more wealth than any other innovation in history - creating hundreds of thousands of ne...Chaikin Analytics | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aethlon Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aethlon Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
